Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation

AIM: To develop an appropriate dosing strategy for continuous intravenous infusions (CII) of enoxaparin by minimizing the percentage of steady-state anti-Xa concentration (C(ss)) outside the therapeutic range of 0.5–1.2 IU ml(−1). METHODS: A nonlinear mixed effects model was developed with NONMEM® f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Feng, Yan, Green, Bruce, Duffull, Stephen B, Kane-Gill, Sandra L, Bobek, Mary B, Bies, Robert R
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2006
Matèries:
Pharmacodynamics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885085/
https://ncbi.nlm.nih.gov/pubmed/16842391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02650.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars